Evidence map›Paper›PMID 31709808›Full record

ArticleJournal of diabetes science and technology2020

Near-Infrared Optical Nanosensors for Continuous Detection of Glucose.

Long V Le, Gauree S Chendke, Soya Gamsey, Natalie Wisniewski, Tejal A Desai

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Nanotheranostics: application of nanosensors in diabetes management.Journal of diabetes and metabolic disorders · 2023
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Long V LeDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.ORCID 0000-0003-1412-0612
Gauree S ChendkeDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.
Soya GamseyProfusa, Inc., South San Francisco, CA, USA.
Natalie WisniewskiProfusa, Inc., South San Francisco, CA, USA.
Tejal A DesaiDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.ORCID 0000-0003-3409-9208
University of California, San Francisco · USProfusa (United States) · US

Funding

Implantable multi-analyte sensors for the continuous monitoring of body chemistriR01EB016414 · NIBIB · PROFUSA, INC. · PI MCSHANE, MIKE, WISNIEWSKI, NATALIE ANN · 2012 to 2015
$4.9M
NIBIB NIH HHS R01 EB016414
6 · The paper itself

Abstract

backgroundContinuous glucose monitors (CGMs) enable people with diabetes to proactively manage their blood glucose and reduce the risk of hypoglycemia. Commercially available CGMs utilize percutaneous electrodes that, after days to weeks of implantation, are subjected to the foreign body response that severely reduces sensor accuracy. The previous work demonstrated the use of hydrogels containing a glucose-responsive viologen that quenches a nearby fluorophore. Here, we investigate the immobilization of this sensing motif onto a nanoparticle surface and optimize local surface concentrations for optical glucose sensing.

methodsA viologen quencher-fluorescent dye system was incorporated into poly(2-hydroethyl methacrylate) hydrogels in varying quantities to assess the effect of quencher-fluorophore concentration on glucose responsiveness. The sensing motif was then immobilized onto silica nanoparticles by carbodiimide chemistry. Nanosensors with a range of dye and quencher concentrations were challenged for glucose responsiveness to determine the optimal sensor formulation.

resultsWhen incorporated into a hydrogel, high concentrations of viologen quencher and fluorophore were required to permit electron transfer between the two components and yield a detectable glucose response. Immobilization of this glucose-responsive system onto a silica nanoparticle facilitated this electron transfer to yield detectable responses at even low concentrations. Increasing quencher concentration on the nanoparticle, relative to the fluorophore, resulted in the greatest apparent glucose response.

conclusionThe nanoparticle sensors demonstrated excellent glucose response in the physiological range and are a promising tool for real-time glucose tracking.

Indexed as

Biosensing TechniquesBlood GlucoseBlood Glucose Self-MonitoringFluorescent DyesHumansNanoparticlesSpectrometry, FluorescenceSpectroscopy, Near-InfraredSubcutaneous TissueViologensBlood GlucoseFluorescent DyesViologensCGMfluorescenceglucose sensorsimplantablesubcutaneous

Identifiers

PMID31709808
PMCPMC7196875
OpenAlexW2989521199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.